학술논문
950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma
Document Type
article
Author
Hong Liu; Kim Margolin; Antoni Ribas; Adil Daud; Mohammed Milhem; Elizabeth Buchbinder; Geoffrey Gibney; Jason Luke; Diwakar Davar; Takami Sato; Bartosz Chmielowski; Luping Zhao; Yousef Zakharia; Theresa Medina; John Kirkwood; Jiaxin Niu; Anthony Olszanski; Montaser Shaheen; George Weiner; Arthur Krieg; Inderjit Mehmi; Heather Kelley; James Wooldridge; Dmitri Bobilev
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Subject
Language
English
ISSN
2051-1426